IC Pharma SRL
2.9 FTEThe score of IC Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +20 % Total assets +31 % Headcount (avg FTE) -24 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
IC Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 128,641 € | ||||
| Equity | 500,272 € | ||||
| Cash | 267,263 € | ||||
| EBITDA | 187,285 € | ||||
| Total assets | €3.17m |
Filed annual accounts
- Year ended 30 Jun 2025filed on 28 Jan 2026
- Year ended 30 Jun 2024filed on 28 Feb 2025
- Year ended 30 Jun 2023filed on 29 Jan 2024
- Year ended 30 Jun 2022filed on 13 Feb 2023
- Year ended 30 Jun 2021filed on 30 Dec 2021
IC Pharma's financial analysis
- Solvency15.8%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of IC Pharma
IC Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0505.707.124
- VAT number
- BE0505707124
- Peppol
- Registered · 0208:0505707124 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Nov 2014
- Registered office
- 1480 Tubize
- Size
- Micro · 2.9 FTE
- Latest accounts
- 2025 · filed on 28 Jan 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
IC Pharma (SRL) has been based in Tubize since 2014, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 128,641 € and equity of 500,272 €; its revenue is not published. With 2.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 15.8%, below the median of its sector (43.9%).
Companies similar to IC Pharma
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Moovartes Wholesale of pharmaceutical and medical goods Genk · balance sheet €3.16m
- Laboratoires Gilbert Benelux Wholesale of pharmaceutical and medical goods Lessines · balance sheet €3.18m
Frequently asked questions about IC Pharma
What is the revenue of IC Pharma?
IC Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of IC Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0505707124 for IC Pharma, if the company is VAT-registered. Its company number (CBE) is 0505.707.124.
Where is the registered office of IC Pharma?
According to the CBE register, the registered office of IC Pharma is in 1480 Tubize.
What is the equity of IC Pharma?
At the close of the 2025 financial year, the equity of IC Pharma amounts to 500,272 €, a solvency of 15.8% of total assets.
How many people work at IC Pharma?
2.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages IC Pharma?
The register lists 3 active mandates at IC Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of IC Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →